Christophe Priou

Christophe Priou is an experienced leader in the pharmaceutical and biotechnology sectors, currently serving as CEO and COO at the European Research Biology Center since November 2019, successfully managing the carve-out and integration of RTC. Previously, Christophe held roles as CEO & Managing Director at CP Pharma Consulting, where expertise in Pharma R&D and transition management was demonstrated, and as Head of Development at Laboratoires Théa. Significant experience also includes executive positions at Charles River Laboratories, WIL Research, and Sanofi Pasteur, managing large teams and overseeing critical quality control and safety assessment operations. Early career contributions were made at Merck Sharp & Dohme and Pfizer, specializing in toxicology, and academic roles included lecturing on pharmacy and toxicology. Educational qualifications include a D.V.M. from Ecole nationale vétérinaire de Nantes, a Master's in Toxicology from the University of Surrey, and a foundation in biology and physiology.